FindTrial
Sign In

Heart Failure management by COmbination of STatin and ARB

Heart Failure management by COmbination of STatin and ARB - HF-COSTAR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000000622
Enrollment
40
Registered
2007-03-01
Start date
2003-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

ARB group ARB+STATIN group

Sponsors

Department of Cardiovascular Medicine, Tokyo Medical and Dental University
Lead Sponsor
Department of Cardiovascular Medicine, Akita University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients of chronic heart failure

Exclusion criteria

Exclusion criteria: The patient who is improper of this study.

Design outcomes

Primary

MeasureTime frame
Hositalization and death caused by heart failure Left ventricular ejection fraction (measured by echocardiography)—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026